|
|
Volumn 12, Issue 8, 2001, Pages 1139-1143
|
|
Phase II trial dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282
a
|
|
Author keywords
Dacarbazine; Islet cell tumors; Pancreas; Phase II
|
|
Indexed keywords
CHLOROZOTOCIN;
DACARBAZINE;
DNA TOPOISOMERASE INHIBITOR;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
GEMCITABINE;
GRANISETRON;
IRINOTECAN;
OCTREOTIDE;
ONDANSETRON;
OXALIPLATIN;
PACLITAXEL;
PHENOTHIAZINE;
PLATINUM;
SEROTONIN ANTAGONIST;
STREPTOZOCIN;
TOPOTECAN;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BLEEDING;
BLOOD TOXICITY;
CANCER SIZE;
CANCER SURVIVAL;
CLINICAL STUDY;
CLINICAL TRIAL;
DEPRESSION;
DRUG RESPONSE;
DRUG TOXICITY;
FEMALE;
HEART INFARCTION;
HUMAN;
LETHALITY;
MAJOR CLINICAL STUDY;
MALE;
NEUROTOXICITY;
ORGANIZATION;
PANCREAS ISLET CELL CARCINOMA;
PARANOIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SEPSIS;
SEPTIC SHOCK;
SIDE EFFECT;
STATISTICAL ANALYSIS;
SYMPTOM;
VOMITING;
ADENOMA, ISLET CELL;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
DACARBAZINE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PANCREATIC NEOPLASMS;
SURVIVAL ANALYSIS;
|
|
EID: 0034823957
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011632713360 Document Type: Article |
|
Times cited : (170)
|
|
References (15)
|
